According to filings with the U.S. Securities and Exchange Commission, Xtant Medical is raising $15,000,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Scott Neils played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Xtant Medical
Xtant Medical (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.

To learn more about Xtant Medical, visit http://xtantmedical.com/

Contact:
Scott Neils, Chief Financial Officer
406-388-0480

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.